189 related articles for article (PubMed ID: 31730285)
1. Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis.
Mitani S; Kadowaki S; Oze I; Masuishi T; Narita Y; Bando H; Oonishi S; Hirayama Y; Tanaka T; Tajika M; Koide Y; Kodaira T; Abe T; Muro K
Cancer Med; 2020 Jan; 9(1):394-400. PubMed ID: 31730285
[TBL] [Abstract][Full Text] [Related]
2. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
3. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
[TBL] [Abstract][Full Text] [Related]
6. Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502.
Mitani S; Kato K; Daiko H; Ito Y; Nozaki I; Kojima T; Yano M; Nakagawa S; Ueno M; Watanabe M; Tsunoda S; Abe T; Kadowaki S; Kadota T; Sasaki K; Machida R; Kitagawa Y
J Gastroenterol; 2022 Jul; 57(7):455-463. PubMed ID: 35546373
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer.
Kagei K; Hosokawa M; Shirato H; Kusumi T; Shimizu Y; Watanabe A; Ueda M
Jpn J Clin Oncol; 2002 Apr; 32(4):120-7. PubMed ID: 12072421
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors Linking Esophageal Squamous Cell Carcinoma With Head and Neck Cancer or Gastric Cancer.
Onochi K; Shiga H; Takahashi S; Watanabe N; Fukuda S; Ishioka M; Koizumi S; Matsuhasi T; Jin M; Iijima K
J Clin Gastroenterol; 2019 Apr; 53(4):e164-e170. PubMed ID: 29498952
[TBL] [Abstract][Full Text] [Related]
9. The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.
Lee KD; Lu CH; Chen PT; Chan CH; Lin JT; Huang CE; Chen CC; Chen MC
BMC Cancer; 2009 Oct; 9():373. PubMed ID: 19843324
[TBL] [Abstract][Full Text] [Related]
10. Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.
Yamaguchi T; Kato K; Nagashima K; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Ito Y; Itami J; Boku N; Higuchi K
Int J Clin Oncol; 2018 Aug; 23(4):652-658. PubMed ID: 29520523
[TBL] [Abstract][Full Text] [Related]
11. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study.
Chen SC; Teng CJ; Hu YW; Yeh CM; Hung MH; Hu LY; Ku FC; Tzeng CH; Chiou TJ; Chen TJ; Liu CJ
PLoS One; 2015; 10(1):e0116384. PubMed ID: 25635388
[TBL] [Abstract][Full Text] [Related]
12. Risk of second cancer in esophageal squamous cell carcinoma and adenocarcinoma survivors: a population-based analysis in SEER dataset.
Qi X; Su X; Wang C; Yao Q; Fan Y
Transl Gastroenterol Hepatol; 2023; 8():33. PubMed ID: 38021360
[TBL] [Abstract][Full Text] [Related]
13. Risks of second malignancies after breast cancer treatment: Long-term results.
Bazire L; De Rycke Y; Asselain B; Fourquet A; Kirova YM
Cancer Radiother; 2017 Feb; 21(1):10-15. PubMed ID: 28034681
[TBL] [Abstract][Full Text] [Related]
14. Second primary esophageal or lung cancer in patients with head and neck carcinoma in Taiwan: incidence and risk in relation to primary index tumor site.
Chen MC; Chen PT; Chan CH; Yang CT; Chen CC; Huang CE; Lu CH; Lee KD
J Cancer Res Clin Oncol; 2011 Jan; 137(1):115-23. PubMed ID: 20306087
[TBL] [Abstract][Full Text] [Related]
15. Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.
Chow JCH; Au KH; Mang OWK; Cheung KM; Ngan RKC
Asia Pac J Clin Oncol; 2019 Feb; 15(1):48-55. PubMed ID: 29932287
[TBL] [Abstract][Full Text] [Related]
16. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
[TBL] [Abstract][Full Text] [Related]
17. Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.
Engelhardt M; Ihorst G; Landgren O; Pantic M; Reinhardt H; Waldschmidt J; May AM; Schumacher M; Kleber M; Wäsch R
Haematologica; 2015 Oct; 100(10):1340-9. PubMed ID: 26160877
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of colon cancer after external radiation therapy for prostate cancer.
Rapiti E; Fioretta G; Verkooijen HM; Zanetti R; Schmidlin F; Shubert H; Merglen A; Miralbell R; Bouchardy C
Int J Cancer; 2008 Sep; 123(5):1141-5. PubMed ID: 18546265
[TBL] [Abstract][Full Text] [Related]
19. Mortality from extrathymic malignancy after thymic tumour resections: incidences and risk factors.
Hamaji M; Sozu T; Machida R; Watanabe SI; Yoshida K; Toyooka S; Tanahashi M; Kondo K; Horio H; Okumura M; Date H
Interact Cardiovasc Thorac Surg; 2019 Nov; 29(5):729-736. PubMed ID: 31326986
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of active operation during intensive followup for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma.
Motoyama S; Saito R; Kitamura M; Ogawa J
J Am Coll Surg; 2003 Dec; 197(6):914-20. PubMed ID: 14644278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
